Tajudeen O Jimoh

Dr. Tajudeen O Jimoh

Islamic University in Uganda, Mbale, Uganda
+1
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2010 in American Journal of Applied Sciences
Verified
Journal Article
Open access
PDF file
JYJ. Yisa
J. Yisa
TJTajudeen O Jimoh
Tajudeen O Jimoh
Analytical Studies on Water Quality Index of River Landzu


29 August 2019 in Journal of Food Biochemistry
Verified
Journal Article
Closed access
PDF file
AAAdedayo Ademiluyi
Adedayo Ademiluyi
OOOlubukola H. Oyeniran
Olubukola H. Oyeniran
TJTajudeen O Jimoh
Tajudeen O Jimoh
GOGaniyu Oboh
Ganiyu Oboh
ABAline A. Boligon
Aline A. Boligon

29 March 2022 in Molecules
Verified
Journal Article
Open access
PDF file
TJTajudeen O Jimoh
Tajudeen O Jimoh
BCBruno Cesar Costa
Bruno Cesar Costa
CCChaisak Chansriniyom
Chaisak Chansriniyom
CCChatchai Chaotham
Chatchai Chaotham
PCPithi Chanvorachote
Pithi Chanvorachote
Boonchoo SritularakBoonchoo Sritularak
Boonchoo Sritularak
From the aerial parts of Cymbidium ensifolium, three new dihydrophenanthrene derivatives, namely, cymensifins A, B, and C (1–3) were isolated, together with two known compounds, cypripedin (4) and gigantol (5). Their structures were elucidated by analysis of their spectroscopic data. The anticancer potential against various types of human cancer cells, including lung, breast, and colon cancers as well as toxicity to normal dermal papilla cells were assessed via cell viability and nuclear staining assays. Despite lower cytotoxicity in lung cancer H460 cells, the higher % apoptosis and lower % cell viability were presented in breast cancer MCF7 and colon cancer CaCo2 cells treated with 50 µM cymensifin A (1) for 24 h compared with the treatment of 50 µM cisplatin, an available chemotherapeutic drug. Intriguingly, the half-maximum inhibitory concentration (IC50) of cymensifin A in dermal papilla cells at >200 µM suggested its selective anticancer activity. The obtained information supports the further development of a dihydrophenanthrene derivative from C. ensifolium as an effective chemotherapy with a high safety profile for the treatment of various cancers.

1 June 2016 in Journal of Taibah University Medical Sciences
Verified
Journal Article
Open access
SAStephen Adefegha
Stephen Adefegha
GOGaniyu Oboh
Ganiyu Oboh
OOOlasunkanmi S. Omojokun
Olasunkanmi S. Omojokun
TJTajudeen O Jimoh
Tajudeen O Jimoh
SOSunday I. Oyeleye
Sunday I. Oyeleye
ObjectiveThis study sought to determine the antioxidant activities of African birch leaf, to assess its interaction with key enzymes relevant to type 2 diabetes (α-amylase and α-glucosidase) and to evaluate its effect on acarbose in vitro.MethodsOne milligram per milliliter of aqueous extract of African birch and acarbose were separately prepared. At the same time, both the African extract and acarbose solution (50:50 v/v) were thoroughly mixed until homogeneity was attained. The phenolic phytoconstituents and antioxidant properties of African birch leaf were subsequently determined. Finally, the effects of African birch extract, acarbose solution and a mixture of acarbose and African birch extract on α-amylase and α-glucosidase activities were assessed in vitro.ResultsThe results showed that African birch extract demonstrated a remarkable antioxidant effect, as exemplified by its radical scavenging abilities, Fe2+ chelating ability and prevention of lipid peroxidation. Acarbose had significantly (p < 0.05) higher α-amylase (IC50 = 11.77 μg/ml) and α-glucosidase (IC50 = 9.05 μg/ml) activities compared to African birch extract [α-amylase (IC50 = 242.17 μg/ml); α-glucosidase (IC50 = 196.35 μg/ml)]. However, the combination of acarbose and African birch extract showed an additive effect on α-amylase inhibition, while a resultant synergistic action was observed against α-glucosidase inhibition.ConclusionThe additive and synergistic actions of the combination of African birch extract and acarbose solution suggest effective, complementary and alternative strategies towards the management/treatment of hyperglycaemia associated with type 2 diabetes

1 December 2017 in Biochemistry and Biophysics Reports
Verified
Journal Article
Open access
TJTajudeen O Jimoh
Tajudeen O Jimoh
AAAdedayo Ademiluyi
Adedayo Ademiluyi
GOGaniyu Oboh
Ganiyu Oboh
ABAline A. Boligon
Aline A. Boligon
•A focused on the erectogenic potentials of two tropical pumpkin seeds was established.•The antioxidant properties of these seed varieties were also discussed.•The inhibitory effects of the seeds on key enzymes relevant to ED were critically explored.•The potentials of the seeds to manage ED were recommended.